Trials / Sponsors / Targeted Therapy Technologies, LLC
Targeted Therapy Technologies, LLC
Industry · 5 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | Retinoblastoma Phase II Expanded Access Clinical Trial Retinoblastoma | Phase 2 | 2025-02-21 |
| Unknown | Topotecan Episcleral Plaque for Treatment of Retinoblastoma Retinoblastoma | Phase 1 | 2021-06-16 |
| Unknown | Phase I Study of Episcleral Celecoxib for Treatment of Macular Edema and Inflammatory Disorders of the Posteri Macula Edema, Radiation Retinopathy, Branch Retinal Vein Occlusion | Phase 1 | 2021-03-05 |
| Unknown | Episcleral Dexamethasone for Treatment of Macular Edema and Inflammatory Disorders of the Posterior Pole Macular Edema, Radiation Retinopathy, Branch Retinal Vein Occlusion | Phase 1 | 2019-09-01 |
| Unknown | A Phase I Study of Episcleral Dexamethasone for Treatment of Macular Edema Refractory Diabetic Macular Edema | Phase 1 | 2019-04-03 |